- Radiotherapy dose de-escalation in patients with high grade non-Hodgkin lymphoma in a real-world clinical practice
-
Yadav BS, Dey T
- KMID: 2549372
- Radiat Oncol J.
- 2023 Dec;41(4):237-247.
- doi: 10.3857/roj.2023.00339
Purpose: The standard treatment of non-Hodgkin lymphoma (NHL) comprises combined modality treatment, radiotherapy (RT), and chemotherapy with rituximab which has significantly improved both disease-free survival (DFS) and overall survival (OS).... -
- CITED
-
- Close
- SHARE
-
- Close
- Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
-
Yadav BS, Gupta S, Dahiya D, Gupta A, Oinam AS
- KMID: 2532064
- Radiat Oncol J.
- 2022 Jun;40(2):127-140.
- doi: 10.3857/roj.2021.01053
Purpose: To assess the feasibility of accelerated hypofractionated radiotherapy with simultaneous integrated boost (SIB) in patients with breast cancer. Materials and Methods: A total of 27 patients after breast-conserving surgery were... -
- CITED
-
- Close
- SHARE
-
- Close
- Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer
-
Yadav BS, Bansal A, Kuttikat PG, Das D, Gupta A, Dahiya D
- KMID: 2503429
- Radiat Oncol J.
- 2020 Jun;38(2):109-118.
- doi: 10.3857/roj.2020.00129
Purpose: Hypofractionated radiotherapy (RT) is becoming a new standard in postoperative treatment of patients with early stage breast cancer after breast conservation surgery. However, data on hypofractionation in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
